​

Curanex Pharmaceuticals Ownership | Who Owns Curanex Pharmaceuticals?

OverviewFinancialsChart

Curanex Pharmaceuticals Ownership Summary

Curanex Pharmaceuticals is owned by 1.16% institutional investors, 67.82% insiders, and 31.03% retail investors.

CURX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCuranex Pharmaceuticals1.16%67.82%31.03%
SectorHealthcare Stocks 35.38%11.35%53.27%
IndustryBiotech Stocks 33.91%11.39%54.70%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268-27.27%327,761-22.90%141.59%4-42.86%433.33%
Dec 31, 20251110.00%425,12948.60%1133.49%7-30.00%3-
Sep 30, 202510-286,093-1-10---

CURX Ownership FAQ

Who Owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals shareholders are primarily institutional investors at 1.16%, followed by 67.82% insiders and 31.02% retail investors. The average institutional ownership in Curanex Pharmaceuticals's industry, Biotech Stocks , is 33.91%, which Curanex Pharmaceuticals falls below.

Does Blackrock own Curanex Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Curanex Pharmaceuticals.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools